Sponsored Research
Pamela S. Douglas of Cardiology has received a sub-award (1R01-CA196854-01) through the City of Hope for a project entitled "Reducing Risk of Anthracycline-related Heart Failure after Childhood Cancer." Total funding will be $16,232.
Robert J. Noveck of Cardiology has received an award (5UM-1AI104681-03) from the National Institutes of Health for a project entitled "PROOF DCRU."
Manesh R. Patel of Cardiology has received an award from the Colorado Prevention Center for a project entitled "VOYAGER PAD." Total funding will be $73,744.
Matthew T. Roe of Cardiology has received an award from the Patient-Centered Outcomes Research Institute for a project entitled "Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE)." Total funding will be $14,729,583.
Matthew T. Roe of Cardiology has received an award from the State of Texas for a project entitled "Mission Lifeline Texas State System Report." Total funding will be $3,671.
Frank Huynh (Mentor: Matthew D. Hirschey) of Endocrinology, Metabolism, and Nutrition has received an award from the Canadian Diabetes Association for a project entitled "The Role of Adipose-Specific SIRT3 in Regulating Glucose and Lipid Metabolism." Total funding will be $29,900.
Mehri McKellar of Infectious Diseases has received a sub-award (U10-HA29297) through Vanderbilt University Medical Center for a project entitled "Regional AIDS Education and Training Centers." Total funding will be $97,516.
Jason E. Stout of Infectious Diseases has received a sub-award through Family Health International for a project entitled "Tuberculosis Trial Consortium." Total funding will be $16,423.
Michael A. Hauser of Medical Genetics has received a sub-award (P50-NS071674) through the National Institutes of Health for a project entitled "Miami Sub for Sample Collection." Total funding will be $13,036.
Virginia B. Kraus of Rheumatology and Immunology has received an award (W81XWH-12-1-0622) from the Department of Defense for a project entitled "Assessment of Biomarkers Associated with Joint Injury and Subsequent Post-Traumatic Arthritis." Total funding will be $341,583.
Industry-sponsored Clinical Trials
Karen P. Alexander of Cardiology has received an award from Sanofi US for a project entitled "A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Alirocumab in Patients with Hypercholesterolemia Not Adequately Controlled with Non-statin L." Total funding will be $16,558.
Pamela S. Douglas of Cardiology has received an award from the General Electric Company for a project entitled "GE Echo Contrast." Total funding will be $192,663.
Zainab Samad of Cardiology has received an award from Bracco Diagnostics, Inc. for a project entitled "A Prospective Multicenter Phase III Clinical Evaluation of the Safety and Efficacy of LumasonTM/SonoVue® in Subjects Undergoing Pharmacologic Stress Echocardiography with Dobutamine for the Diagnosis for Coronary Artery Disease." Total funding will be $136,717.
Tracy Y. Wang of Cardiology has received an award from AstraZeneca Pharmaceuticals, LP for a project entitled "Day-by-Day Program." Total funding will be $96,541.
Andrew J. Muir of Gastroenterology has received an award from TaiwanJ Pharmaceuticals Co. Ltd for a project entitled "A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis Patients who are Refractory or Intolerant to Current Therapies." Total funding will be $1,317,655.
Andrew J. Muir of Gastroenterology has received an award from Gilead Sciences, Inc. for a project entitled "HCV RNA Monitoring System." Total funding will be $250,982.
Kenneth E. Schmader of Geriatrics has received an award from Novavax, Inc. for a project entitled "A Phase III Randomized, Observer-Blind, Placebo-Controlled Study to Demonstrate the Efficacy of Respiratory Syncytical Virus (RSV) Recombinant F Nanoparticale Vaccine in Prevention of Acute, Symptomatic RSV-Associated Respiratory Disease, and Acute." Total funding will be $1,245,152.
Daniel J. George of Medical Oncology has received an award from Celldex Therapeutics, Inc. for a project entitled "A Phase I/II, Open-label, Dose-escalation Study of Varlilumab (CDX-1127) in Combination with Atezolizumab (MPDL3280A, Anti-PD-L1) in Patients with Advanced Cancer." Total funding will be $163,095.
Herbert I. Hurwitz of Medical Oncology has received an award from Acerta Pharma for a project entitled "A Phase 2 randomized proof of concept study of Nab-Paclitaxel/Gemcitabine alone and in combination with ACP-196 in subjects with previously untreated metastatic pancreatic cancer.” Total funding will be $265,284.
Michael A. Morse of Medical Oncology has received an award from MedImmune, Inc. for a project entitled "A Study of safety tolerability and clinical activity of MEDI4736 and Tremelimumab administered as monotherapy and in combination to subjects with unresectable heptocellular carcinoma." Total funding will be $448,390.
Andrew B. Nixon of Medical Oncology has received an award from Incyte Corporation for a project entitled "Combination JAK1 inhibition and PD-L1 checkpoint blockade therapy for colorectal cancer." Total funding will be $121,722.
Hope E. Uronis of Medical Oncology has received an award from Advaxis Inc for a project entitled "A Phase 2 study of ADXS11-001 i subjects with persistent/recurrent loco-regional or metastatic squamous cell carcinoma of the anorectal canal." Total funding will be $275,976.
Thomas M. Coffman of Nephrology has received an award from ChemoCentryx, Inc. for a project entitled "ChemoCentryx Protocol--Acute Studies." Total funding will be $16,591.
Shelby Reed of Other Medicine has received an award from Janssen Research & Development, LLC for a project entitled "Janssen BACEi - Benefit Risk Tradeoff Preferences of Asymptomatic Alzheimer's." Total funding will be $245,746.
Megan E. Clowse of Rheumatology and Immunology has received an award from Janssen Scientific Affairs, LLC for a project entitled "A Retrospective Review of Treatments in Pregnant Psoriatic Arthritis Patients." Total funding will be $123,352.
Ankoor Shah of Rheumatology and Immunology has received an award from Cytori Therapeutics, Inc. for a project entitled "STAR Scleroderma." Total funding will be $172,210.